Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Microbiol ; 28(2): 356-7, 1990 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2312679

RESUMO

A new laboratory animal model for experimental cryptosporidiosis is described. Adult immunosuppressed hamsters were infected per os with 0.5 x 10(5) and 1 x 10(5) Cryptosporidium oocysts of calf origin. The mean numbers of oocysts shed per gram of feces per day and the patterns of infection are described. The susceptibility to Cryptosporidium infection, the total number of oocysts shed (a thousand times the infective dose), and the ease of handling in laboratory conditions make hamsters a good animal model for cryptosporidiosis.


Assuntos
Criptosporidiose/etiologia , Animais , Cricetinae , Criptosporidiose/parasitologia , Cryptosporidium/isolamento & purificação , Modelos Animais de Doenças , Fezes/parasitologia , Feminino , Terapia de Imunossupressão
3.
Clin Chem ; 35(1): 81-5, 1989 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-2463120

RESUMO

We developed a solid-phase two-site immunoenzymometric assay (IEMA) of the estrogen-induced 52-kDa cathepsin D (EC 3.4.23.5) and its processed forms (48-kDa and 34-kDa proteins) in cytosols of breast cancer tissues, using two monoclonal antibodies directed against two different epitopes of these antigens. The first antibody is bound to a polystyrene microtiter well; the second is labeled with alkaline phosphatase. The assay involves a simultaneous incubation of the antigen with both antibodies, because we observed signal loss during sequential incubations. Alkaline phosphatase was chosen because other enzymes (peroxidase, beta-galactosidase) were inhibited by cytosol extraction buffers. The measurable range of 52-kDa-related proteins is from 0.3 to 6 nmol/L with precision (CVs) within and between runs of 3.9% and 15.8%, respectively. The sensitivity, accuracy, and rapid turnaround time of the two-site IEMA should facilitate the clinical evaluation of this new marker in oncology.


Assuntos
Neoplasias da Mama/análise , Catepsina D/análise , Técnicas Imunoenzimáticas , Fosfatase Alcalina , Anticorpos Monoclonais , Antígenos de Neoplasias/imunologia , Citosol/análise , Epitopos/imunologia , Humanos , Peso Molecular , Controle de Qualidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...